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ABSTRACT We have tested the hypothesis that severe acute respiratory syndrome (SARS) coronavirus protein E (SCoVE)
and its homologs in other coronaviruses associate through their putative transmembrane domain to form homooligomeric
a-helical bundles in vivo. For this purpose, we have analyzed the results of molecular dynamics simulations where all possible
conformational and aggregational space was systematically explored. Two main assumptions were considered; the ﬁrst is that
protein E contains one transmembrane a-helical domain, with its N- and C-termini located in opposite faces of the lipid bilayer.
The second is that protein E forms the same type of transmembrane oligomer and with identical backbone structure in different
coronaviruses. The models arising from the molecular dynamics simulations were tested for evolutionary conservation using 13
coronavirus protein E homologous sequences. It is extremely unlikely that if any of our assumptions were not correct we would
ﬁnd a persistent structure for all the sequences tested. We show that a low energy dimeric, trimeric and two pentameric models
appear to be conserved through evolution, and are therefore likely to be present in vivo. In support of this, we have observed
only dimeric, trimeric, and pentameric aggregates for the synthetic transmembrane domain of SARS protein E in SDS. The
models obtained point to residues essential for protein E oligomerization in the life cycle of the SARS virus, speciﬁcally N15. In
addition, these results strongly support a general model where transmembrane domains transiently adopt many aggregation
states necessary for function.
INTRODUCTION
Coronaviruses, which belong to the family Coronaviridae,
cause common colds in humans and are responsible for
serious diseases in other species. Recently, one of its
members has been found to be the causative agent of the
severe acute respiratory syndrome (SARS) (Rota et al.,
2003). Coronaviruses are surrounded by a lipid bilayer, or
envelope, which typically embeds three proteins: spike (S),
matrix (M), and the E protein. The envelope surrounds a
nucleocapsid, containing the viral RNA and nucleocapsid
(N) protein. Proteins S, M, and N have been studied for their
important roles in receptor binding and virion budding. For
example, the envelope spike protein S mediates attachment
to cellular receptors and entry by fusion with cell mem-
branes, whereas the matrix protein M is involved in budding
and interacts with N and S proteins (Opstelten et al., 1995;
Narayanan et al., 2000).
The signiﬁcance of the E protein, however, has proved
more elusive, but appears to be critical for viral budding, as
charged-to-alanine mutations in mouse hepatitis virus
(MHV) have been found to produce dramatic morphological
changes in the virions (Fischer et al., 1998). Additionally,
although in many coronaviruses expression of M protein on
its own is not sufﬁcient to produce virus-like particles, co-
expression of proteins M and E can readily produce them
(Bos et al., 1996; Vennema et al., 1996; Baudoux et al.,
1998; Corse and Machamer, 2000). Proteins M and E have
been found to interact via their cytoplasmic domains in pre-
Golgi compartments (Lim and Liu, 2001). Another role
suggested for protein E has been in promoting apoptosis (An
et al., 1999; Chen et al., 2001), an effect that can be opposed
by Bcl-2. Further, recent data (Liao et al., 2004) suggests that
SARS coronavirus E protein (SCoVE) can increase mem-
brane permeability and may have ion channel activity.
Despite, or because of, its small size, the topology of
protein E is still a matter of controversy. Some reports (Corse
and Machamer, 2000) have suggested that protein E in IBV
traverses the Golgi lipid bilayer once, with the N-terminus
facing the Golgi lumen and the C-terminus facing the
cytoplasm. Another group (Maeda et al., 2001) has sug-
gested that protein E inMHV traverses the lipid bilayer twice,
whereby both N- and C-termini of the protein would reside
in the cytoplasm, which is topologically equivalent to the in-
terior of the viral envelope. Even more recently, based on in
vitro biophysical studies (Arbely et al., 2004) a short hairpin
(12 amino acids long) has been suggested for the putative
transmembrane domain of SCoVE.
The explanation for these seemingly conﬂicting reports
may be either of experimental origin or perhaps related to the
protein’s reported varied functionality. In any case, protein E
clearly has the potential to perturb or permeabilize lipid
bilayers (Fischer et al., 1998), but the structural determinants
involved (pores, hairpins) have not been clearly deﬁned.
To predict a possible transmembrane oligomer of protein
E, we have worked under the assumption that protein E
contains one transmembrane domain with its N- and
C-termini in opposite sides of the membrane (Corse and
Machamer, 2000). We have then performed global searching
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molecular dynamics simulations (Adams et al., 1995) using
only the transmembrane sequence of protein E (TME). As
the oligomeric size of the hypothetic bundle is not known,
we explored different oligomeric sizes, from dimers to
hexamers. This procedure was performed on 13 different
sequence variants, to select a model that would be
evolutionarily conserved (Briggs et al., 2001). The latter
strategy has already been used successfully to predict correct
models for transmembrane peptides known to form dimers
(Briggs et al., 2001), trimers (Kukol et al., 2002), tetramers
(Torres et al., 2002a,b), or pentamers (Torres et al., 2002a)
for which experimental data was available a priori, and the
validity of the predictions could be readily assessed. In this
study in contrast, neither the precise topology of protein E,
nor the oligomeric size, helix tilt, and helix rotational orien-
tation of the hypothetic a-helical bundle were known.
We reasoned that if a structure could be found that was not
affected by any conservative mutation, and if a large number
sequences with rather low similarity were used, it would be
extremely unlikely that this should happen by chance and
therefore the structure should be present in vivo. Surpris-
ingly, we found not one, but four homooligomeric models,
a dimer, a trimer and two pentamers, for the transmembrane
domain of the coronavirus E protein.
MATERIALS AND METHODS
Homologous sequences and predicted
transmembrane domains
The sequence of SCoVE (Fig. 1) was obtained from Swiss-Prot and
TrEMBL (http://ca.expasy.org/sprot/sprot-top.html), and its homologous
sequences were obtained using the FASTA server (http://www.ebi.ac.uk/
fasta33). In total, 13 homologous sequences were used in this study with
a minimum similarity of 17% in their predicted transmembrane domain (see
Fig. 2). The complete names of these sequences, the abbreviation used in
Fig. 2 (within parentheses), and Swiss-Prot entries are: SARS coronavirus E
protein (SCoVE), P59637; small envelope protein from SARS coronavirus
BJ01 (SCoV_BJ01), Q6QJ39; envelope protein from feline coronavirus
(FCoV), O12296; envelope protein from canine coronavirus (CCoV),
Q7T6T0; envelope protein from canine enteric coronavirus, strain Insavc-1
(CCoV_Insacv1), VEMP_CVCAI; envelope protein from porcine trans-
missible gastroenteritis coronavirus, strain Purdue (TGEV_purdue),
VEMP_CVPPU; envelope protein from porcine respiratory coronavirus,
strain RM4 (PrCoV_RM4), VEMP_CVPRM; putative small membrane
protein from porcine transmissible gastroenteritis coronavirus, strain FS772/
70 (TGEV_FS772/70), VSMP_CVPFS; small membrane protein E from
porcine hemagglutinating encephalomyelitis virus (PHEV), Q84730; small
membrane protein from Rat sialodacryoadenitis coronavirus (RCoV),
Q9IKC8; small membrane protein from Murine hepatitis virus (MHV),
O72007; envelope protein from Human coronavirus, strain 229E
(HcoV_229E), VEMP_CVH22; and putative small membrane protein
from Avian infectious bronchitis virus, strain M41 (IBV_M41),
VSMP_IBVM.
The assignment of the transmembrane domain for each sequence was
based on the hydrophilicity/surface probability plots (Kyte and Doolittle,
1982; Emini et al., 1985) and the transmembrane prediction on the TMHMM
server (http://www.cbs.dtu.dk/services/TMHMM) (Krogh et al., 2001).
According to these predictors, the transmembrane region for the sequences
spans ;24 residues and the following residues were used for the simu-
lations: 11–34 for sequences SCoVE, SCoV_BJ01, RCoV, and MHV;
14–37 for sequences CCoV_Insavc1, THEV_purdue, PRCOV_RM4,
TGEV_FS772/70, FCoV, and CCoV; 10–33 for sequence HcoV_229E;
and 13–36 for sequences PHEV and IBV_M41, all containing the same
number of residues, i.e., 24.
Global search molecular dynamics
(GSMD) protocol
For the simulations we used a Hewlett-Packard Alpha SC45 Cluster
containing 44 nodes. All calculations were performed using the Parallel
Crystallography and NMR System (PCNS), the parallel-processing version
of the Crystallography and NMR System (CNS Version 0.3) (Brunger et al.,
1998), with united atom topology (Jorgensen and Tirado-Rives, 1988)
explicitly describing only polar and aromatic hydrogen atoms. A global
search was carried out in vacuo as described elsewhere (Adams et al., 1995),
using CHI 1.1 (CNS Helical Interactions) and assuming a symmetrical
interaction between the helices in the homooligomer.
Trials were carried out starting from either left or right crossing
conﬁgurations. The helix tilt, b, was restrained to 0 and the helices were
rotated a total of 350 about their long helical axes, in 10 increments.
Henceforth, the simulation was repeated by increasing the helix tilt in
discrete steps of 5, up to 40. We should point out, however, that this
restraint is not completely strict, and the helix tilt at the end of the simulation
can drift up to 65 from the restrained value.
Three trials were carried out from each starting conﬁguration using
different initial random velocities. Increasing oligomeric sizes were
examined, from 2 (dimers) to 6 (hexamers). Each protocol was repeated
for up to 13 different sequences (Fig. 2). Hence, a total of 9 (tilt) 3 36
FIGURE 1 Complete sequence of SCoVE. The predicted TME used in
the simulations is indicated (shaded bar). The corresponding transmembrane
sequence used for other variants is shown in the alignment of Fig. 2. Three
cysteines (black circles) C40, C43, and C44 are indicated, which are
possible palmitoylation sites.
FIGURE 2 Sequences corresponding to the putative transmembrane seg-
ments of SARS coronavirus E protein and its homologous used in our
molecular dynamics simulations. The column on the left indicates their
abbreviated name. The complete name and corresponding Swiss-Prot entries
are indicated in the Materials and Methods section. The numbering cor-
responds to SCoVE. The residue used to calculate the rotational orientation,
v23, for the models in Figs. 3–5 is indicated by an asterisk.
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(rotation) 3 5 (size) 3 13 (sequences) 3 3 (repeats) 3 2 (handedness) ¼
126,360 structures were produced and analyzed, i.e., 25,272 for each
oligomeric size and 1,944 for each sequence and a given oligomeric size.
For each oligomeric size and helix tilt, clusters with a minimum number
of structures (typically 10) were identiﬁed, where any structure belonging to
a particular cluster was typically within 1.0 A˚ RMSD (root mean-square
deviation) from any other structure within that cluster. The structures
belonging to each cluster were averaged and subjected to energy mini-
mization. These ﬁnal structures were taken as the representative of the
clusters and represented in the plots (see Figs. 3–5).
Analysis of the simulations
As previously (Briggs et al., 2001; Torres et al., 2002a), the results from the
GSMD simulations were represented graphically by plotting each
representative structure as a function of two parameters, helix tilt, b, and
rotational orientation, v of a speciﬁc residue, in the ordinate and abcissa
axis, respectively. As described previously (Arkin et al., 1997), the rotational
orientation angle v is deﬁned by the angle between a vector perpendicular to
the helix axis, oriented toward the middle of the peptidic C¼O bond of the
residue, and a plane that contains both the helical axis and the normal to the
bilayer. This angle is 0when the residue is located in the direction of the tilt.
For all representations in Figs. 3–5, the rotational orientation v was deﬁned
relative to residue 23, indicated as v23, in the sequence SCovE (see asterisk
symbol in Fig. 2), and its equivalent residue for other sequences. The tilt
angle of the models, b, was taken as the average of the angles between each
helix axis in the bundle and the bundle axis. The bundle axis, coincident with
the normal to the bilayer, was calculated by CHI. The helix axis was
calculated as a vector with starting and end points above and below a deﬁned
residue, where the points correspond to the geometric mean of the
coordinates of the ﬁve a-carbons N-terminal and the ﬁve a-carbons
C-terminal to the deﬁned residue. Intersequence comparisons between low
energy clusters were performed by calculating the RMSD between their
a-carbon backbones. Fitting was performed using the program ProFit (http://
www.bioinf.org.uk/software/proﬁt). The energies calculated correspond to
the total energy of the system, including both bonded, e.g., bond, angle,
dihedral, improper, and nonbonded, i.e., van der Waals and electrostatic
terms (Adams et al., 1995).
FIGURE 3 (a) Plot of helix tilt versus v23 for the low energy models
(each symbol represents one model) obtained after the GSMD simulations
for a homodimeric model when restraining the helix tilt to 10. For each
sequence, the horizontal broken line separates left-handed (symbols above
the broken line) from right-handed bundles (symbols below the broken line).
The vertical broken line indicates the average orientation (at v ¼ 23)
where the complete set was found (RMSD, 1.5 A˚; n ¼ 10 structures). The
models inside the small rectangles are those forming a complete set. (b) The
models in panel a are represented as a function of their energy (ordinate axis)
and v23. The lowest energy models found in each sequence are indicated
with a shaded rectangle.
FIGURE 4 As in Fig. 3, but assuming a homotrimeric homooligomer.
This ﬁgure only shows the results when the helix tilt was restrained to 35.
The vertical broken line indicates the orientation at v ¼ 113, where the
complete set was found (RMSD, 1 A˚; n ¼ 10).
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Synthesis of the transmembrane peptide of SARS
protein E and SDS-PAGE electrophoresis
The peptide corresponding to the transmembrane helix of SARS protein E
was synthesized in a Respep peptide synthesizer (Intavis Bioanalytical
Instruments AG, Cologne, Germany), using standard solid-phase FMOC
chemistry, from residue 9 to 35, and adding 2 lysines to both N- and
C-ends, to improve solubility. The exact sequence used was KKTGTLI-
VNSVLLFLAFVVFLLVTLAILTKK, amidated and acylated at C- and
N-termini, respectively. The peptide was cleaved from the resin with
triﬂuoroacetic acid (TFA) and lyophilized. The lyophilized peptides were
dissolved in triﬂuoroethanol (TFE), TFA and acetonitrile (1:1:4, v/v/v)
(ﬁnal peptide concentration ;5 mg/ml) and immediately injected to a
20-ml Juppiter 5 C4-300 column (Phenomenex, Cheshire, UK) equilibrated
with H2O. Peptide elution was achieved with a linear gradient to a ﬁnal
solvent composition of 10% H2O, 90% acetonitrile, using a Waters 600
HPLC system. All solvents contained 0.1% (v/v) TFA. The resulting
fractions were pooled and lyophilized. Peptide purity was conﬁrmed by
mass spectrometry.
The electrophoretic mobility of the peptide was assessed using SDS/
PAGE. SDS sample buffer was added to the lyophilized peptide to a ﬁnal
concentration of 2 mg/ml. After vortexing for 1 min the sample was heated at
70C for 5 min and loaded on a 15% SDS-PAGE gel (Tris Glycine). The
loading volumes were 5, 10, and 20 ml. The sample was electrophoresed
at room temperature at a constant voltage of 100 V for 30 min. After
completion, the SDS/PAGE gel was ﬁrst stained with Coomassie blue,
followed by silver staining with the Silver stain-Plus kit (Bio-Rad).
RESULTS
Homodimer simulations
Fig. 3 (panel a) shows the results of the simulations when
TME was assumed to be a homodimeric a-helical bundle.
Only the results corresponding to a restrained helix tilt to 10
are shown, because no persistent models were found at any
other helix tilt tested. The preserved conﬁguration is right-
handed (models below the horizontal broken line) and has an
average orientation of b ¼ 12 and v23 ¼ 23 (vertical
broken line). To guide the eye, the models consistent with
this conﬁguration for each of the sequences have been
enclosed within a small rectangle. We note that helix tilt
versus v is just a convenient way of representation, and
structures with up to 20 difference in the v for a certain
residue can in fact be very similar, e.g., for SCoVE v23 is
33, not 23.
No structure within this set, which spans all sequences
tested, was found to differ from any other in the same set by
more than 1.5 A˚ Ca RMSD. This RMSD value is higher
than that reported previously (below 1 A˚ RMSD) using the
same method for various other homooligomers (Briggs
et al., 2001), which casts some doubts on the relevance of
this structure. However, one must take into account the low
similarity between the transmembrane sequences used here
(17%) compared to those used in previous work (more than
50%) (Briggs et al., 2001; Torres et al., 2002a). It is
therefore possible that the high RMSD observed is due to
the low similarity of the sequences used, which in turn may
indicate that the structure represented by these sequences is
not identical. In fact we have observed a smaller RMSD
(1.15 A˚) when using sequences from the same coronavirus
group.
We can also assess the relevance of this model by
observing the energy values obtained in each simulation
(Torres et al., 2002a). If the model is correct, the lowest
energy models for each sequence will tend to cluster around
that particular conformation. Panel b in Fig. 3 shows that the
lowest energy models (highlighted by shading) for each
sequence cluster around v ¼ 23 (vertical dotted line),
which is where the persistent conformation appears. We
conclude therefore that protein E forms a homodimeric
structure. Slices corresponding to this dimeric model for
sequence SCoVE are represented in Fig. 6 (left column).
Homotrimer simulations
Fig. 4 shows the results of the simulations assuming a
homotrimeric a-helical bundle when the helix tilt was
FIGURE 5 As in Fig. 3, but assuming a homopentameric homooligomer.
Only restraining the helix tilt to 25 (shown here), a complete set was found
(RMSD, 1A˚; n ¼ 10). The vertical broken lines indicate the orientation of
the complete sets found, at v¼121 (form A) and at v¼176 (form B).
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restrained to 35. Only in this case a persistent left-handed
conformation was found, at b ¼ 32, v ¼ 113. No
structure within this complete set (see symbols within small
rectangles) differed from any other in the same set by more
than 1 A˚ Ca RMSD. As in the case of the dimer, the energy
plot in panel b shows that the lowest energy model for each
simulation-sequence appears at, or near, the v representing
the complete set. The slices corresponding to this trimeric
model are presented in Fig. 6.
Homotetramer simulations
For the homotetramer, no complete set like those described
for dimer and trimer could be found for any restrained helix
tilt, even at 2 A˚ Ca RMSD. The results are not shown.
Homopentamer simulations
Fig. 5 (panel a) shows the results of the simulations assuming
a homopentameric arrangement. In this case, only when the
helix was restrained to 25 and in a left-handed conﬁguration,
not one, but two persistent models were found. Onemodel (A)
appeared at b ¼ 23, v ¼ 121 (right vertical broken line)
and the other model (B) appeared at b¼ 20, v¼176 (left
vertical broken line). No structure within each of these
complete sets represented by models A and B differed from
any other structure in the same set by more than 1.0 A˚ Ca
RMSD.When we tried to determine which of the models was
correct based on their energies (panel b) we found that, except
for PHEV, all lowest energy models are close or near
v ¼ 121, i.e., form A, which is a strong indication that
model A is the correct one and model B must be a false
positive. Intriguingly however, for the outlier sequence
PHEV, the lowest energy model is equivalent precisely to
form B (v ¼ 176). We hypothesize that models A and B
could represent closed (low energy) and open (high energy)
forms of a channel (see Discussion). Slices through both
structures are given in Fig. 6 (two columns on the right).
Homohexamer simulations
As for the tetramer, no complete set could be found for any
restrained helix tilt, even at 2 A˚ Ca RMSD. The results are
not shown. Higher order oligomers were not tested.
SDS-PAGE of the transmembrane domain of
SARS protein E
To assess experimentally the aggregation state of coronavi-
rus protein E, the synthetic transmembrane domain of SARS
protein E (TME) was solubilized in SDS and electrophoresed
(see Materials and Methods). At the three concentrations of
peptide tested (Fig. 7, lanes 2–4), we could observe bands
FIGURE 6 Columns from left to right: slices through the dimeric,
trimeric, pentameric-form A and pentameric-form B of the transmembrane
domain of SARS coronavirus E protein, i.e., sequence SCoVE in Fig. 2.
Color code: L, green; V, cyan; I, salmon; A, marine; F, blue; N, orange; and
S and T, red. For clarity’s sake, the residue numbers are indicated only in one
of the helices of the trimeric model. Note the central role of N15 for the three
types of oligomers.
FIGURE 7 SDS-PAGE electrophoresis corresponding to the synthetic
transmembrane peptide of SARS protein E. Lane 1 (left) shows the
molecular weight markers. Lanes from 2 to 4: increasing load of peptide: 10,
20, and 40 mg, respectively. Arrows indicate the bands corresponding to the
dimer, trimer, and pentameric forms of the peptide. The bands corresponding
to the pentamer in lanes 2 and 3 were visible only after silver staining.
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consistent with the presence of dimers, trimers and pen-
tamers in SDS. Coomassie blue staining was sufﬁcient for
the most concentrated lane (lane 4), but after silver staining
also lanes 2 and 3 showed the presence of the three oligomers.
No other oligomeric form was detected.
DISCUSSION
After an exhaustive exploration of the conformational space
of the transmembrane domain of protein E (TME), we have
found that only a dimer (b ¼ 12, right-handed), a trimer
(b ¼ 35, left-handed), and two pentamers (b ¼ 25, both
left-handed) have been conserved by the conservative muta-
tions appeared during evolution.
We note that, in contrast with previous work (Briggs et al.,
2001; Kukol et al., 2002; Torres et al., 2002a), where we
successfully obtainedmodels in agreement with experimental
data, no indication exists regarding the existence of a trans-
membrane a-helical homooligomer of coronavirus protein E
in vivo or in vitro. Also, no structural data is available that
permits to conﬁrm or discard a given model. Could then these
models have been conserved just by chance?
The ﬁrst indication this is not the case is the extremely low
probability that a model would survive all the conservative
mutations present in 13 sequences with a similarity of only
17%. Clearly, the probability of ﬁnding a model only by
chance decreases when the number of sequences analyzed
is increased. Also, the lower the similarity between these se-
quences, the more stringent is the selection procedure, and
the similarity between the sequences used here is as small as
17%, far below 50% used in previous work (Briggs et al.,
2001).
The second indication that supports our prediction is based
on the relative energies of the resulting models. If the correct
model is the most stable, then it is expected that for every
sequence the lowest energy model will be close to that
represented by the complete set. Because of inaccuracies in
the force-ﬁelds and other factors however, not all lowest
energy models will have the same conformation, but they
will cluster around the conformation of the correct structure,
as conﬁrmed previously in other proteins (Torres et al.,
2002a). Consistent with this, the lowest energy models found
in each aggregation state, dimeric, trimeric, or pentameric,
for every sequence tested, cluster around the conformation of
the persistent model.
The third indication is that, as we show in Fig. 7, the
transmembrane domain of SARS protein E is sufﬁcient to
form dimeric, trimeric, and pentameric homooligomers in
SDS micelles. Recent in vivo studies performed on the whole
protein (Liao et al., 2004) also show dimers and trimers in
nonreducing conditions, but only monomers in reducing
conditions which prevent disulﬁde bond formation between
monomers via the extramembrane cysteine residues (see Fig.
1). Overall, these combined results suggest that although the
speciﬁcity in the interactions between monomers resides in
the transmembrane domain, a dramatic effect on oligomer-
ization is contributed by the extramembrane domain,
speciﬁcally, but possibly not limited to, intermonomer
disulﬁde bonds. In addition, the reported membrane
permeabilizing activity of SCoVE (Liao et al., 2004) is
consistent with our prediction of a pentameric bundle or
pore, for which we ﬁnd two close conformations, A and B.
Although based on their energy values only model A appears
to be correct, it is intriguing that the only persistent models
found after a systematic search for a homopentamer should
have the same handedness and helix tilt and be separated by
a rotation of their helices of just 55. We propose therefore
that these two models could represent open and closed states
of a channel, as both conformations should have been
equally conserved during evolution. This is clearly reminis-
cent of phospholamban, where the possible existence of two
transmembrane homopentameric models separated only by
a rotation of their helices of;40 has been discussed (Torres
et al., 2001, 2002a).
The fourth and ﬁnal indication is that we have predicted
previously, using a method similar to the one described here,
a transmembrane homotetrameric form for a component of
the T-cell receptor, CD3-z (Torres et al., 2002b) for which
only homodimers have been found experimentally. Recently,
this prediction was partially conﬁrmed by the observation of
a homotetrameric form of the cytoplasmic domain of CD3-z
(Sigalov et al., 2004) that could only be detected at very high
concentrations. As both CD3-z and protein E are targeted
to lipid rafts, it is possible that the local increase in con-
centration catalyzes the formation of many types of olig-
omers.
Another implication of this work is on protein E topology.
Our results implicitly support a topology for protein E where
N- and C-termini are in opposite sides of the membrane
(Corse and Machamer, 2000). The latter authors showed
unquestionably that the long hydrophilic tail (C-terminus) is
facing the cytoplasm and therefore should be located in the
inside of the virion envelope. Consistently, Raamsman et al.
(2000) found that protein E was not digested after treating
MHV particles with proteinase K in the absence of detergent.
It was concluded that no part of protein E faces the virus
exterior, although a question should be raised about the
accessibility of such a small N-terminus to proteinase K
(;10 amino acids, probably associated to the membrane). In
fact, Yu et al. (1994) showed previously using an antibody
against protein E in MHV that protein E was accessible from
the surface of the virion envelope. Recently, Maeda et al.
(2001) targeted a hydrophylic peptide (a ﬂag) added to either
the N- or the C-termini of protein E with antibodies and
suggested that both N- and C-termini of the protein would
reside in the cytoplasm, i.e., topologically equivalent to the
virus lumen. These authors argued that an alternative
explanation for the data reported by Corse and Machamer
(2000) was that although both C and N are in the cytoplasmic
domain, the N-terminus was simply too short to be targeted
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by the antibody. Even more recently, in vitro biophysical
studies (Arbely et al., 2004) have led to the suggestion that
the putative TM domain of protein E forms a short hairpin
that inserts only partially in the membrane.
We do not discard that more than one structural model for
protein E can be present during the virion cycle, attending to
its putative functional diversity. These different structural
models could arise in different environments. For example,
many viral envelope proteins contain putative palmitoylated
sites and it is thought that this modiﬁcation is important in
protein-protein interactions during virus assembly. Palmi-
toylation may also induce raft partitioning, as shown for
example in HIV-1 envelope glycoproteins (Bhattacharya
et al., 2004). The cytoplasmic tail of SCovE, for example,
contains one or more putative palmitoylation sites, and
speciﬁcally, a ‘‘double cysteine’’ CC motif, which is a strong
predictor of palmitoylation, as exempliﬁed in various
receptors (Bijlmakers and Marsh, 2003). In addition, in
IBV (Corse and Machamer, 2002) and in MHV (Yu et al.,
1994) protein E has already been shown to be palmitoylated.
It is possible that this reversible covalent modiﬁcation could
trigger conformational changes critical for function. Physical
interaction of this domain with the M protein is critical in the
formation of the virion (Lim and Liu, 2001). An interesting
possibility therefore is that palmitoylation and the sub-
sequent close association of the cytoplasmic tail to the lipid
bilayer may trigger a conformational change, or even the
formation of a TM hairpin. Both in vitro and in vivo studies
are currently being performed in our labs to test each of these
hypotheses.
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